Evidence map›Paper›PMID 39232585›Full record

ReviewESMO open2024

Adequate assessment yields appropriate care-the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group.

K P Loh, G Liposits, S P Arora, N R Neuendorff, F Gomes, J L Krok-Schoen, T Amaral, E Mariamidze, L Biganzoli, E Brain and 8 more

Abstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in ESMO open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

K P LohDivision of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA. Electronic address: education@esmo.org.
G LipositsDepartment of Oncology, Odense University Hospital, Odense, Denmark. Electronic address: https://twitter.com/G_LipositsMD.
S P AroraDivision of Hematology/Oncology, Department of Medicine, Mays Cancer Center, University of Texas Health San Antonio, San Antonio, USA. Electronic address: https://twitter.com/DrSukeshiArora.
N R NeuendorffDepartment of Geriatrics, Marien Hospital Herne, University Hospital, Ruhr University Bochum, Herne, Germany. Electronic address: https://twitter.com/neuendorff_nr.
F GomesMedical Oncology Department, The Christie NHS Foundation Trust, Manchester; Senior Adult Oncology, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: https://twitter.com/FabioGomes_go.
J L Krok-SchoenComprehensive Cancer Center, The Ohio State University, Columbus; School of Health and Rehabilitation Sciences, The Ohio State University College of Medicine, Columbus, USA. Electronic address: https://twitter.com/KrokSchoen.
T AmaralCenter for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: https://twitter.com/TeeresaSAmaral.
E MariamidzeTodua Clinic-Department of Oncology and Hematology, Tbilisi, Georgia; Ospedale Policlinico San Martino-Clinica di Oncologia Medica, Genoa. Electronic address: https://twitter.com/EMariamidze.
L Biganzoli"Sandro Pitigliani" Department of Medical Oncology, Hospital of Prato, Prato, Italy.
E BrainDepartment of Medical Oncology, Institut Curie/Saint-Cloud, Saint-Cloud. Electronic address: https://twitter.com/EtienneB66.
C BaldiniDrug Development Department (DITEP), Gustave Roussy, Villejuif; Paris Saclay University, Villejuif, France. Electronic address: https://twitter.com/CapuBaldini.
N M L BattistiDepartment of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: https://twitter.com/nicolobattisti.
M FrélautDepartment of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: https://twitter.com/frelaut_m.
R KanesvaranDepartment of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore. Electronic address: https://twitter.com/ravikanesvaran.
A R A MislangCollege of Medicine and Public Health, Flinders University, Adelaide; Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Adelaide, Australia. Electronic address: https://twitter.com/AnnaMislang.
D PapamichaelDepartment of Medical Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
C SteerBorder Medical Oncology, Albury Wodonga Regional Cancer Centre, Albury; UNSW School of Clinical Medicine, Rural Clinical Campus, Albury; John Richards Centre for Rural Ageing Research, La Trobe University, Wodonga, Australia. Electronic address: https://twitter.com/drcbsteer.
S RostoftInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo; Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway. Electronic address: https://twitter.com/SRostoft.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the aging population, older adults constitute a growing proportion of the new cancer cases. Given the heterogeneous health status among older adults and their susceptibility to aging-related vulnerabilities, understanding their diversity and its implications becomes increasingly crucial for prognostication and guiding diagnostics, treatment decisions, and follow-up, as well as informing supportive care interventions. Geriatric assessment and management (GAM) refers to the comprehensive evaluation of an older individual's health status with subsequent management plans focusing on both oncologic and non-oncologic interventions. In 2019, the European Society for Medical Oncology (ESMO) and the International Society of Geriatric Oncology (SIOG) established the ESMO/SIOG Cancer in the Elderly Working Group. This position paper reflects the recommendations of the working group. Our paper summarizes the existing evidence with a focus on recent key trials and based on this, we propose several recommendations and future directions.

Indexed as

Geriatric AssessmentNeoplasmsAgedAged, 80 and overGeriatricsHumansMedical Oncologycancergeriatric assessmentmanagementolder adults

Identifiers

PMID39232585
PMCPMC11410714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.